The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers

FASEB Journal

Volumn 27, Issue 5, 2013, Pages 1847-1858

  Younan, Nadine D ^a   Sarell, Claire J ^a   Davies, Paul ^b   Brown, David R ^b   Viles, John H ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

Antiparallel; Electron microscopy; IR; NMR; PrP; Sheet; Structure

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; OLIGOMER; PRION PROTEIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; STOICHIOMETRY;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; BINDING SITES; HUMANS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PRPC PROTEINS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84877144645     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-222588     Document Type: Article

References (54)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics. Science 297, 353-356
2. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539
3. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95, 6448-6453
4. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132
5. Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Lauren, J., Gimbel, Z. A., and Strittmatter, S. M. (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374
6. Gunther, E. C., and Strittmatter, S. M. (2010) Beta-amyloid oligomers and cellular prion protein in Alzheimers disease. J. Mol. Med. (Berl.) 88, 331-338
7. Chen, S., Yadav, S. P., and Surewicz, W. K. (2010) Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues. J. Biol. Chem. 285, 26377-26383
8. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., Chiesa, R., Gobbi, M., Salmona, M., and Forloni, G. (2010) Synthetic amyloid-oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U. S. A. 107, 2295-2300
9. Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I. M., and Aguzzi, A. (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314
10. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010) The prion protein as a receptor for amyloid-beta. Nature 466, E3-E4; discussion E4-E5
11. Cisse, M., Sanchez, P. E., Kim, D. H., Ho, K., Yu, G. Q., and Mucke, L. (2011) Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427-10431
12. Freir, D. B., Nicoll, A. J., Klyubin, I., Panico, S., Mc Donald, J. M., Risse, E., Asante, E. A., Farrow, M. A., Sessions, R. B., Saibil, H. R., Clarke, A. R., Rowan, M. J., Walsh, D. M., and Collinge, J. (2011) Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336
13. Barry, A. E., Klyubin, I., Mc Donald, J. M., Mably, A. J., Farrell, M. A., Scott, M., Walsh, D. M., and Rowan, M. J. (2011) Alzheimers disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci. 31, 7259-7263
14. You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D., Lipton, S. A., Stys, P. K., and Zamponi, G. W. (2012) Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 109, 1737-1742
15. Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E. C., and Strittmatter, S. M. (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci. 15, 1227-1235
16. Bate, C., and Williams, A. (2011) Amyloid-beta-induced synapse damage is mediated via cross-linkage of cellular prion proteins. J. Biol. Chem. 286, 37955-37963
17. Kudo, W., Lee, H. P., Zou, W. Q., Wang, X., Perry, G., Zhu, X., Smith, M. A., Petersen, R. B., and Lee, H. G. (2012) Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death. Hum. Mol. Genet. 21, 1138-1144
18. Hyeon, J. W., Kim, S. Y., Park, J. S., Choi, B. Y., Lee, S. M., Ju, Y. R., An, S. S., and Kim, C. K. (2012) The association between prion proteins and Abeta(1-42) oligomers in cytotoxicity and apoptosis. Biochem. Biophys. Res. Commun. 424, 214-220
19. Caetano, F. A., Beraldo, F. H., Hajj, G. N., Guimaraes, A. L., Jurgensen, S., Wasilewska-Sampaio, A. P., Hirata, P. H., Souza, I., Machado, C. F., Wong, D. Y., De Felice, F. G., Ferreira, S. T., Prado, V. F., Rylett, R. J., Martins, V. R., and Prado, M. A. (2011) Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J. Neurochem. 117, 538-553
20. Zou, W. Q., Xiao, X., Yuan, J., Puoti, G., Fujioka, H., Wang, X., Richardson, S., Zhou, X., Zou, R., and Li, S. (2011) Amyloid beta interacts mainly with insoluble prion protein in the Alzheimer brain. J. Biol. Chem. 286, 15095-15105
21. Ferrer, I., Blanco, R., Carmona, M., Puig, B., Ribera, R., Rey, M., and Ribalta, T. (2001) Prion protein expression in senile plaques in Alzheimers disease. Acta Neuropathol. 101, 49-56
22. Parkin, E. T., Watt, N. T., Hussain, I., Eckman, E. A., Eckman, C. B., Manson, J. C., Baybutt, H. N., Turner, A. J., and Hooper, N. M. (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimers amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 104, 11062-11067
23. Gacia, M., Safranow, K., Styczynska, M., Jakubowska, K., Peplonska, B., Chodakowska-Zebrowska, M., Przekop, I., Slowik, A., Golanska, E., Hulas-Bigoszewska, K., Chlubek, D., Religa, D., Zekanowski, C., and Barcikowska, M. (2006) Prion protein gene M129 allele is a risk factor for Alzheimers disease. J. Neural. Transm. 113, 1747-1751
24. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23
25. Calero, O., Bullido, M. J., Clarimon, J., Frank-Garcia, A., Martinez-Martin, P., Lleo, A., Rey, M. J., Rabano, A., Blesa, R., Gomez-Isla, T., Valdivieso, F., de Pedro-Cuesta, J., Ferrer, I., and Calero, M. (2011) Genetic cross-interaction between APOE and PRNP in sporadic Alzheimers and Creutzfeldt-Jakob diseases. PLoS One 6, e22090
26. Herms, J., Tings, T., Gall, S., Madlung, A., Giese, A., Siebert, H., Schurmann, P., Windl, O., Brose, N., and Kretzschmar, H. (1999) Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19, 8866-8875
27. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 13363-13383
28. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., and Wuthrich, K. (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature 382, 180-182
29. Wuthrich, K., and Riek, R. (2001) Three-dimensional structures of prion proteins. Adv. Protein. Chem. 57, 55-82
30. Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E., and Dyson, H. J. (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. U. S. A. 94, 13452-13457
31. Viles, J. H., Donne, D., Kroon, G., Prusiner, S. B., Cohen, F. E., Dyson, H. J., and Wright, P. E. (2001) Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics. Biochemistry 40, 2743-2753
32. OSullivan, D. B., Jones, C. E., Abdelraheim, S. R., Brazier, M. W., Toms, H., Brown, D. R., and Viles, J. H. (2009) Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region. Protein Sci. 18, 410-423
33. Klewpatinond, M., Davies, P., Bowen, S., Brown, D. R., and Viles, J. H. (2008) Deconvoluting the Cu2 binding modes of fulllength prion protein. J. Biol. Chem. 283, 1870-1881
34. Nadal, R. C., Davies, P., Brown, D. R., and Viles, J. H. (2009) Evaluation of copper2 affinities for the prion protein. Biochemistry 48, 8929-8931
35. Younan, N. D., Klewpatinond, M., Davies, P., Ruban, A. V., Brown, D. R., and Viles, J. H. (2011) Copper(II)-induced secondary structure changes and reduced folding stability of the prion protein. J. Mol. Biol. 410, 369-382
36. Viles, J. H. (2012) Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimers, Parkinsons and prion diseases. Coord. Chem. Rev. 256, 2271-2284
37. Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., and Zamponi, G. W. (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 181, 551-565
38. Sarell, C. J., Syme, C. D., Rigby, S. E., and Viles, J. H. (2009) Copper(II) binding to amyloid-beta fibrils of Alzheimers disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form. Biochemistry 48, 4388-4402
39. OSullivan, D. B., Jones, C. E., Abdelraheim, S. R., Thompsett, A. R., Brazier, M. W., Toms, H., Brown, D. R., and Viles, J. H. (2007) NMR characterization of the pH 4 beta-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility. Biochem. J. 401, 533-540
40. Sarell, C. J., Wilkinson, S. R., and Viles, J. H. (2010) Substoichiometric levels of Cu2 ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-from Alzheimer disease. J. Biol. Chem. 285, 41533-41540
41. Uversky, V. N., Li, J., and Fink, A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human-synuclein. J. Biol. Chem. 276, 44284
42. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489
43. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., and Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291
44. Miyazawa, T., and Blout, E. R. (1961) The infrared spectra of polypeptides in various conformations: amide I and II bands1. J. Am. Chem. Soc. 83, 719-712
45. Cerf, E., Sarroukh, R., Tamamizu-Kato, S., Breydo, L., Derclaye, S., Dufrene, Y. F., Narayanaswami, V., Goormaghtigh, E., Ruysschaert, J. M., and Raussens, V. (2009) Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. Biochem. J. 421, 415-423
46. Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., Cascio, D., Glabe, C., and Eisenberg, D. (2012) Atomic view of a toxic amyloid small oligomer. Science 335, 1228-1231
47. Xue, W. F., Hellewell, A. L., Gosal, W. S., Homans, S. W., Hewitt, E. W., and Radford, S. E. (2009) Fibril fragmentation enhances amyloid cytotoxicity. J. Biol. Chem. 284, 34272-34282
48. Watt, N. T., Taylor, D. R., Gillott, A., Thomas, D. A., Perera, W. S., and Hooper, N. M. (2005) Reactive oxygen speciesmediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 280, 35914-35921
49. Muramoto, T., Scott, M., Cohen, F. E., and Prusiner, S. B. (1996) Recombinant scrapie-like prion protein of 106 amino acids is soluble. P. Natl. Acad. Sci. U. S. A. 93, 15457-15462
50. Morales, R., Estrada, L. D., Diaz-Espinoza, R., Morales-Scheihing, D., Jara, M. C., Castilla, J., and Soto, C. (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimers and prion diseases. J. Neurosci. 30, 4528-4535
51. Yerbury, J. J., Poon, S., Meehan, S., Thompson, B., Kumita, J. R., Dobson, C. M., and Wilson, M. R. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 21, 2312
52. Stanyon, H. F., and Viles, J. H. (2012) Human serum albumin can regulate amyloid-beta peptide fiber growth in the brain interstitium: implications for Alzheimer disease. J. Biol. Chem. 287, 28163-28168
53. Andreetto, E., Yan, L.-M., Tatarek-Nossol, M., Velkova, A., Frank, R., and Kapurniotu, A. (2010) Identification of hot regions of the AIAPP interaction interface as high-affinity binding sites in both cross-and self-association. Angew. Chem. Int. Ed. 49, 3081-3085
54. Nieznanski, K., Choi, J. K., Chen, S., Surewicz, K., and Surewicz, W. K. (2012) Soluble prion protein inhibits amyloid-(A-) fibrillization and toxicity. J. Biol. Chem. 287, 33104-33108